Long-term follow-up for vaccines may seem to be a distant concern when clinical trials are just beginning, but it can be critical to have a plan for follow-up at the outset. Learn considerations for follow-up design, s...
Press releases
-
ICON plc to present at the 43rd annual J.P. Morgan healthcare conference
ICON plc today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025 at 3.45pm PST.
-
ICON and its employees celebrated for excellence in the field of clinical research
ICON plc has been honoured with numerous awards in the second half of 2024.
-
ICON announces appointment of Chief Operating Officer
Appointment of Barry Balfe as Chief Operating Officer (COO).
-
ICON survey highlights sustained investment in AI and digital R&D innovation, tempered by siloed adoption
Survey spotlights shifting expectations and more measured pace of innovation as use of digital solutions matures within the biotech and pharma industry.
-
ICON reports third quarter 2024 results
ICON plc today reported its financial results for the third quarter ended September 30, 2024
-
ICON survey highlights scale of focus on precision therapies in increasingly complex oncology landscape
ICON plc today announced results from a recent survey of over 100 professionals engaged in oncology drug development to understand the current state of emerging oncology treatment development, including the associated clinical trial dynamics.
-
ICON announces appointment of new Chief Financial Officer (CFO)
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced the appointment of Nigel Clerkin as its new Chief Financial Officer (CFO).
-
ICON reports second quarter 2024 results
ICON plc today reported its financial results for the second quarter ended June 30, 2024.
-
ICON announces results of Annual General Meeting and changes to the Board of Directors
ICON plc announced that all resolutions at the Annual General Meeting of the company (AGM) held on July 23, 2024 were duly passed by shareholders.
-
ICON recognised for leadership position in clinical research industry and as socially responsible employer
At the CRO Leadership Awards 2024, ICON was recognised for its excellence in clinical research in all categories.
